The Biden Administration has been extremely busy this summer, with the development of new initiatives designed to reform the healthcare system in the U.S. The focus has been on so-called “junk fees” hidden in almost every sector of the economy, as well as lowering healthcare costs for Americans. And three recent actions in particular have emphasized just how important this is to the Administration – even in the face of criticism and legal action.
The Federal Trade Commission (FTC) recently withdrew two policy statements that deal with competition in healthcare. They were originally published in 1996 and 2011, but the agency stated that given how much things have changed since then, they are “outdated and no longer reflect market realities.
And while policy statements are non-binding and don’t set any legal requirements, the FTC did state that it believes removing these two statements will significantly help promote fair competition in healthcare.
But that doesn’t mean that the FTC is exiting stage left from antitrust enforcement. It will just now look at mergers and conduct reviews on a case-by-case basis.
Not everyone is pleased by this move, however, with the American Hospital Association (AHA) citing their disappointment that the agency withdrew, rather than modernized, the written guidelines – and did not have a conversation with stakeholders in the field about doing so.
The Consumer Financial Protection Bureau (or CFPB), U.S. Department of Health and Human Services (HHS), and the U.S. Department of the Treasury recently announced a joint request for information (RFI) on medical credit cards and installment loans proposed to patients as a way to cover their medical costs.
The agencies hope to obtain commentary on how common these medical credit cards and loans are, what the interest and fees are, patient experiences, and whether they felt that the cards and loans were pushed on them – and if providers are in any way incentivized to offer them (and if so, what types of incentives are offered). They are also hoping to gain information on if these types of medical credit cards and loans for patients are actually making existing healthcare billing and collections issues worse.
The CFPB additionally recently held a hearing on the issue, wherein examples were provided of times in which a consumer felt pressured or uninformed about the patient financing option they selected. The agencies hope that together, they’ll be able to better understand the overall market, as well as how their individual agencies might need to respond through regulation.
The Administration also recently announced new data on how effective the Inflation Reduction Act is expected to be at reducing costs of pharmaceuticals, highlighting an estimated $400 per year savings for Medicare beneficiaries. Just last week, the White House brought in leaders of in retail health to help spread the word about the law and its potential cost savings to the retail chains’ customers: CVS Health, Walgreens, and Walmart stopped by to discuss how to best educate customers about who can benefit and how much, as well as how best to convey that information, whether it be through social media or printing it on customer receipts.
This meeting was held amid the filing of several lawsuits against the Administration on this initiative, however. Multiple pharmaceutical companies and groups have sued over the provision of the Act that allows Medicare to negotiate prices for certain drugs, arguing that the measure is unconstitutional.
It will prove to be a busy next few months for both the Administration and for the industry. But I’ll leave you with these remarks from HHS Secretary Becerra – when asked about some of the challenges the Administration is facing in implementing its initiatives, he stated it “won’t be deterred” and “isn’t letting anything get in our way” when it comes to lowering healthcare costs.
EDITOR’S NOTE: The author of this article used AI-assisted tools in its composition, but all content, analysis, and conclusions were based on the author’s professional
EDITOR’S NOTE: Ongoing discussion about U.S. disengagement from the World Health Organization (WHO), with withdrawal effective Jan. 22, has refocused attention on how global standards
Please log in to your account to comment on this article.
Sepsis sequencing continues to challenge even experienced coding and CDI professionals, with evolving guidelines, documentation gaps, and payer scrutiny driving denials and data inconsistencies. In this webcast, Payal Sinha, MBA, RHIA, CCDS, CDIP, CCS, CCS-P, CCDS-O, CRC, CRCR, provides clear guideline-based strategies to accurately code sepsis, severe sepsis, and septic shock, assign POA indicators, clarify the relationship between infection and organ dysfunction, and align documentation across teams. Attendees will gain practical tools to strengthen audit defensibility, improve first-pass accuracy, support appeal success, reduce denials, and ensure accurate quality reporting, empowering organizations to achieve consistent, compliant sepsis coding outcomes.
Expert presenters Kathy Pride, RHIT, CPC, CCS-P, CPMA, and Brandi Russell, RHIA, CCS, COC, CPMA, break down complex fracture care coding rules, walk through correct modifier application (-25, -57, 54, 55), and clarify sequencing for initial and subsequent encounters. Attendees will gain the practical knowledge needed to submit clean claims, ensure compliance, and stay one step ahead of payer audits in 2026.
Accurately determining the principal diagnosis is critical for compliant billing, appropriate reimbursement, and valid quality reporting — yet it remains one of the most subjective and error-prone areas in inpatient coding. In this expert-led session, Cheryl Ericson, RN, MS, CCDS, CDIP, demystifies the complexities of principal diagnosis assignment, bridging the gap between coding rules and clinical reality. Learn how to strengthen your organization’s coding accuracy, reduce denials, and ensure your documentation supports true medical necessity.
Denials continue to delay reimbursement, increase administrative burden, and threaten financial stability across healthcare organizations. This essential webcast tackles the root causes—rising payer scrutiny, fragmented workflows, inconsistent documentation, and underused analytics—and offers proven, data-driven strategies to prevent and overturn denials. Attendees will gain practical tools to strengthen documentation and coding accuracy, engage clinicians effectively, and leverage predictive analytics and AI to identify risks before they impact revenue. Through real-world case examples and actionable guidance, this session empowers coding, CDI, and revenue cycle professionals to shift from reactive appeals to proactive denial prevention and revenue protection.
In this timely session, Stacey Shillito, CDIP, CPMA, CCS, CCS-P, CPEDC, COPC, breaks down the complexities of Medical Decision Making (MDM) documentation so providers can confidently capture the true complexity of their care. Attendees will learn practical, efficient strategies to ensure documentation aligns with current E/M guidelines, supports accurate coding, and reduces audit risk, all without adding to charting time.
Join Ronald Hirsch, MD, FACP, CHCQM for The PEPPER Returns – Risk and Opportunity at Your Fingertips, a practical webcast that demystifies the PEPPER and shows you how to turn complex claims data into actionable insights. Dr. Hirsch will explain how to interpret key measures, identify compliance risks, uncover missed revenue opportunities, and understand new updates in the PEPPER, all to help your organization stay ahead of audits and use this powerful data proactively.
Stay ahead of the 2026-2027 audit surge with “Top 10 Audit Targets for 2026-2027 for Hospitals & Physicians: Protect Your Revenue,” a high-impact webcast led by Michael Calahan, PA, MBA. This concise session gives hospitals and physicians clear insight into the most likely federal audit targets, such as E/M services, split/shared and critical care, observation and admissions, device credits, and Two-Midnight Rule changes, and shows how to tighten documentation, coding, and internal processes to reduce denials, recoupments, and penalties. Attendees walk away with practical best practices to protect revenue, strengthen compliance, and better prepare their teams for inevitable audits.
As AI reshapes healthcare compliance, the risk of biased outputs and opaque decision-making grows. This webcast, led by Frank Cohen, delivers a practical Four-Pillar Governance Framework—Transparency, Accountability, Fairness, and Explainability—to help you govern AI-driven claim auditing with confidence. Learn how to identify and mitigate bias, implement robust human oversight, and document defensible AI review processes that regulators and auditors will accept. Discover concrete remedies, from rotation protocols to uncertainty scoring, and actionable steps to evaluate vendors before contracts are signed. In a regulatory landscape that moves faster than ever, gain the tools to stay compliant, defend your processes, and reduce liability while maintaining operational effectiveness.
Prepare for the 2025 CMS IPPS Final Rule with ICD10monitor’s IPPSPalooza! Click HERE to learn more
Get 15% OFF on all educational webcasts at ICD10monitor with code JULYFOURTH24 until July 4, 2024—start learning today!
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 1 with code CYBER25
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24
